Scientists reveal good news about South African variant
Friday, March 05, 2021
Two South African laboratories have used different tests to show that antibodies against the variant of the COVID-19 virus known as 501Y.V2, which dominated the second wave of infections in the country, are effective against the original version of the COVID-19 virus.
This means that if a vaccine is designed to target 501Y.V2, it will likely be as effective, or nearly as effective, against earlier strains of the virus. (Vaccines developed against the original strain of the virus are still partially effective against 501Y.V2, albeit less so, and worth having.
The recent Vaccination Day in Motokwe, orchestrated through collaborative efforts between UNICEF, USAID, BRCS, and the Ministry of Health, underscores a commendable stride towards fortifying child health services.The painful reality as reflected by the Ministry of Health's data regarding the decline in routine immunisation coverage since the onset of the pandemic, is a cause for concern.It underscores the urgent need to address the...